Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Recon Therapeutics

Recon Therapeutics
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
$50K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of a drug delivery system. The company develops the LyoKit Disposable Reconstitution System which facilitates self-adminitration of biological drugs.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • Boston, MA
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Recon Therapeutics’s full profile, request a free trial.

Recon Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 28-Oct-2015 $50K 0000 Completed Startup
2. Grant 17-Jun-2014 0000 Completed Startup
1. Grant 01-Jan-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Recon Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
MassChallenge Accelerator/Incubator 000 0000 000000 0
VentureWell Accelerator/Incubator 000 0000 000000 0
Massachusetts Institute of Technology Limited Partner 000 0000 000000 0

Recon Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Benjamin Maimon Ph.D Co-Founder
Christopher Lee Ph.D Co-Founder
John Lewandowski Ph.D Co-Founder